A mutant strain of Streptomyces venezuelae was engineered by deletion of the entire gene cluster related to biosynthesis of the endogenous deoxysugar (TDP-D D-desosamine) and replacement with genes required for biosynthesis of an intermediate sugar (TDP-4-keto-6-deoxy-D D-glucose) or an exogenous sugar (TDP-D D-olivose), from the oleandomycin and urdamycin deoxysugar pathways. The Ôsugar-flexibleÕ glycosyltransferase (DesVII) was able to attach the intermediate sugar and the new sugar to both 12-and 14-membered macrolactones thus producing quinovose or olivose glycosylated 10-deoxymethynolide and narbonolide, respectively. In addition, hydroxylated analogs of the new metabolites were detected. These results demonstrate a successful attempt of engineering the deoxysugar pathway for generation of novel hybrid macrolide antibiotics.
Introduction
The growing number of antibiotic-resistant bacteria has heightened interest towards discovery of novel antibiotics. An approach of modifying natural products by combining existing biosynthetic genes from various related microorganisms to design a pathway for producing a non-natural product known as Ôcombinatorial biosynthesisÕ has recently become a promising method for the development of new antibiotics. The characterization of macrolide antibiotic biosynthetic pathways from different species of Streptomyces has allowed such genetic manipulations to combine genes from various pathways for the biosynthesis of new hybrid macrolides with potential bioactivity [1] . The deoxysugar moiety of macrolide antibiotics has been shown to be essential for the biological activity of the drug [2, 3] and there is considerable interest in the possibility of using combinatorial biosynthesis to generate macrolactones attached with new deoxysugar moieties. Recent reports on the flexibility of glycosyltransferases in accepting non-native sugars as substrate for attachment to specific macrolactones has made these enzymes an important tool for combinatorial biosynthesis of novel compounds with altered glycosylation patterns [4, 5] .
The pikromycin biosynthetic system in S. venezuelae is notable for its natural ability to produce two distinct groups of macrolide antibiotics including the methymycin and pikromycin series macrolides [6, 7] derived from the 12-and 14-membered macrolactones, 10-deoxymethynolide and narbonolide, respectively ( Fig. 1(a) ). Both series of compounds contain an amino deoxysugar, D D-desosamine at position C-3 and C-5 for methymycin and pikromycin, respectively. A cluster of nine open reading frames designated the desosamine (des) cluster has been identified and sequenced from a previous study [6] . Six open reading frames, desI-desVI has been assigned as genes involved in desosamine biosynthesis and recently the biosynthetic pathway for desosamine has been proposed [8] [9] [10] (Fig. 1(b) ). A gene product of desVII has been assigned as a glycosyltransferase responsible for glycosylation of desosamine to both 10-deoxymethynolide and narbonolide [6] . DesR, also located within the des cluster encodes a b-glucosidase involved in a secondary self-protection mechanism [11] . Currently, the gene product of desVIII has not been assigned a function in the pathway towards the biosynthesis of desosamine and remains to be further investigated.
The flexibility of DesVII glycosyltransferase, in accepting new sugar donors as substrate, has been demonstrated from previous reports on its ability to accept the intermediate sugars from the desosamine pathway [8] [9] [10] as well as new sugars such as TDP-L L-rhamnose [12] and TDP-D D-quinovose [13] . DesVII has also been shown to be flexible towards hybrid aglycones to which the sugar is attached [14] . This unique property of Des-VII has allowed researchers to explore the possibility of [13] . In accordance with this finding, the quinovose glycosylated macrolides were produced thus validating the system. Furthermore, we designed a hybrid deoxysugar pathway for the biosynthesis and transfer of a non-native sugar, TDP-D D-olivose ( Fig. 1(b) ).
Materials and methods

Bacterial strains, culture conditions and DNA manipulation
Streptomyces venezuelae ATCC 15439 was used for the construction of mutant strains of S. venezuelae. The wild type and mutant strains were cultured on SPA agar plates under appropriate antibiotic selection as described previously [14] . Escherichia coli DH10B was used as a host for DNA manipulation. DNA isolation and manipulation in E. coli was carried out by standard procedures [15] . Transformation of DNA into protoplasts of S. venezuelae followed standard protocols [16] . Litmus 28 (New England Biolabs) and pGEM-3Zf (+) (Promega) were used for subcloning. Southern blot hybridization made use of the protocols recommended for the DIG labeling and detection kit (Roche).
Construction of S. venezuelae deficient in desosamine biosynthesis
A gene replacement plasmid, pYJ100, derived from pKC1139 [16] that contains an apramycin resistant marker, was constructed for replacement of the entire des cluster by a kanamycin resistance gene (aphII) [17] . pYJ100 was constructed by cloning a kanamycin resistance gene flanked by two 1 kb fragments homologous to the upstream and downstream regions of the des cluster. The following primers with engineered restriction sites (underlined) were used to generate the two 1 kb fragments by polymerase chain reaction (PCR): a 1 kb Hind III-PstI fragment containing the 5 0 -des cluster flanking region, forward 5 0 -GGCAAGCTTAGCGGGGCGAC-TGGCGTGCCCACT-3 0 and reverse 5 0 -GGTCTG-CAGTCACCGTGGGTTCTGCCATCTCTT-3 0 ; and a 1 kb KpnI-EcoRI fragment containing the 3 0 -des cluster flanking region, forward 5 0 -GCTGGTACCGGATGT-TCCCTCCGGGCCACCGTC-3 0 and reverse 5 0 -TGA-GAATTCCCTCGCCGTCCTGCCCGCGCTTGG-3 0 (restriction sites are underlined). pYJ100 was introduced into protoplasts of wild type S. venezuelae for replacement by a replicative plasmid-mediated homologous recombination as described previously [14] . Several double crossover mutants were identified on the basis of their phenotype of kanamycin resistance and apramycin sensitivity and their genotype by southern hybridization. This strain was designated YJ003.
PCR amplification of genes
Several genes were amplified by PCR with specific oligoprimers (Table 1) . Each pair of oligoprimers contained two restriction sites that were designed to facilitate subcloning of each gene ( Table 2) . PCR was performed with Pfu polymerase (Fermentas) under the recommended conditions. DesR, desIII, desIV, desVII and desVIII were PCR amplified from S. venezuelae [6] genomic DNA as template. OleV and oleW were PCR amplified from S. antibioticus Tü 99 [18] genomic DNA as template. The gene urdR was PCR amplified from S. fradiae [19] genomic DNA. The PCR products were subcloned into Litmus 28 or pGEM-3Zf(+) for subsequent sequencing for the correct nucleotide sequence compared to the NCBI nucleotide database.
Construction of plasmids and mutant strains
Three plasmids were constructed for the expression of genes for deoxysugar biosynthesis and glycosylation. In each vector, the cloned genes were expressed under the control of the upstream ermE* promoter [20] . For construction of the first plasmid, based on the integrative plasmid pSET152 [21] derivative containing an ermE* promoter, the PCR products for desR, desIII and desIV were digested by the appropriate restriction enzyme and subcloned in series into Litmus 28. A XbaI-BamHI fragment including these three genes was digested from Litmus 28 and ligated into XbaI/BamHI-digested pSET152 derivative containing an ermE* promoter and designated pYJ136 (Fig. 2(a) ). The plasmid pYJ136 was integrated into the genomic DNA of YJ003 to yield the mutant strain YJ013.
A second plasmid, based on pWHM3 [16] derivative containing an ermE* promoter, was designed for the transfer of TDP-4-keto-6-deoxy-D D-glucose. This plasmid was ligated with the PCR product of desVII digested by XbaI/BamHI and designated pYJ140. The third plasmid was constructed from pYJ140 for the transfer of TDP-D D-olivose. OleV, oleW and urdR PCR products were subcloned into pGEM-3Zf (+) and then a HindIII/XbaI fragment of DNA including all three genes was digested and ligated into the HindIII/XbaI digested pYJ140, which was designated pYJ144. Later desVIII was placed into pYJ140 and pYJ144 to yield plasmids designated pYJ142 and pYJ146, respectively (Fig. 2(b) ). The strain YJ013 was transformed by plasmids pYJ140, 142, 144 and 146 to yield strains YJ018, 019, 020 and 012, respectively.
Production and analysis of macrolide derivatives
Streptomyces venezuelae mutant strains were cultured and metabolites were extracted as described previously [14] . The products were analyzed by liquid chromatography coupled with electrospray ionization-mass/mass spectrometry (LC/ESI-MS/MS). LC was performed with a Waters (Milford, MA) Model 2690 separations module, using a 25 cm · 4.6 mm Watchers 120 ODS-BP (5 lm) column (Daiso Watchers, Osaka, Japan) with 20-80% acetonitrile in water gradient containing 10 mM of ammonium acetate at a flow rate of 1 ml/min. The effluent was split 1:5 before ESI interface, with approximately 200 l/min routed to the Micromass (Beverly, MA) Quattro LC triple tandem quadrupole mass spectrometer. Mass spectrometric data were acquired in the positive-ion mode while scanning the specific parent mass to be fragmented. The relative amount of each compound produced was compared by the peak intensity in the LC-MS.
Results and discussion
S. venezuelae mutant (YJ003) deficient in desosamine biosynthesis
A strain for the biosynthesis of the macrolactones, 10-deoxymethynolide and narbonolide, was constructed by deleting the entire des cluster (desI-desVIII and desR) from the chromosome of S. venezuelae and replaced by a kanamycin resistance gene through a replicative plasmid-mediated homologous recombination. The genomic DNA of this strain was analyzed by Southern hybridization for confirmation of the double crossover (data not shown). The culture extract of strain YJ003 was analyzed and aglycones, 10-deoxymethynolide and narbonolide, were detected corresponding to m/z 319 and 375 for Na + ionized forms, respectively, as monitored by LC-MS (Fig. 3(a) ). Glycosylated compounds were not detected from the culture extract of YJ003.
Plasmid construction for deoxysugar biosynthesis and glycosyltransfer
The plasmid (pYJ136) containing the genes (desIII, desIV) coding for enzymes catalyzing the two early and common steps in the biosynthesis of a key intermediate sugar of macrolide antibiotics (TDP-4-keto-6-dideoxy-D D-glucose) was constructed. A gene (desR) involved in a secondary self-resistance mechanism against the macrolide antibiotic produced by S. venezuelae was also cloned in pYJ136 (Fig. 2(a) ). This plasmid was integrated into the genomic DNA of YJ003 to obtain a strain designated YJ013 that would produce the key intermediate sugar, which is the branching point for various other 6-deoxysugars and consequently this mutant strain could be used as a starting point for the biosynthesis of various deoxysugars. A second plasmid (pYJ140) was constructed to contain the gene encoding a glycosyltransferase (desVII) for attachment of the intermediate sugar to the aglycones. The third plasmid (pYJ144) is a modification of pYJ140 with the addition of three genes (oleV, oleW and urdR) involved in the biosynthesis of TDP-D D-olivose from TDP-4-keto-6-dideoxy-D D-glucose. The function of each gene is summarized in Table 1 . Plasmids pYJ140 and pYJ144 were later modified to also incorporate a gene (desVIII) that seems to be involved in the glycosylation process and designated pYJ142 and pYJ146 ( Fig. 2(b) ), respectively. The strain YJ013 was transformed with pYJ140 and pYJ142, to produce strains YJ018 and YJ019, respectively, for biosynthesis of quinovosyl compounds, and with pYJ144 and pYJ146 to produce strains YJ020 and YJ021 for production of olivosyl compounds.
Production of quinovosyl derivatives
Previous studies have demonstrated the ability of des-VII to accept TDP-4-keto-6-deoxy-D D-glucose as sugar substrate for attachment to 10-deoxymethynolide [13] . The presence of a pathway-independent reductase in S. venezuelae that can stereospecifically reduce this intermediate sugar to D D-quinovose was also proposed ( Fig. 1(b) ). It is uncertain whether this conversion takes place before or after the sugar is attached to the aglycone. To validate the mutant strain YJ013 in biosynthesizing the intermediate sugar, TDP-4-keto-6-deoxy-D D-glucose, plasmid pYJ140 cloned with a gene encoding the glycosyltransferase (desVII) was constructed and transformed into YJ013. However, the resulting strain YJ018, containing the glycosyltransferase (desVII) and TDP-4-keto-6-deoxy-D D-glucose synthesizing genes, did not produce the expected quinovose glycosylated compounds. In a recent in vitro study, the glycosylation of TDP-D D-desosamine to 10-deoxymethynolide required the presence of an additional protein, DesVIII [22] . The participation of DesVIII in glycosylation catalyzed by DesVII was essential but its actual role in catalysis remains unclear. Computational analysis using the BLAST software revealed that DesVIII protein has similarity with dnrQ gene product (35%) from Streptomyces peucetius [23] , AknT (33%) from Streptomyces galilaeus [24] and EryCII (31%) from Saccharopolyspora erythraea [25] . These proteins were found to be essential for the biosynthesis and transfer of the respective deoxysugars but it remains to be demonstrated whether they function as a second protein in the glycosylation of the respective aglycones.
To explore the possibility that this requirement of an additional protein involved in glycosylation not only applies to the aminosugar (TDP-D D-desosamine) but also applies to the transfer of TDP-4-keto-6-deoxy-D D-glucose or TDP-D D-quinovose, the strain YJ019 was constructed with the addition of the desVIII gene. In accordance with previous findings, the compound with mass corresponding to the quinovose glycosylated 10-deoxymethynolide (m/z = 465.4) was detected by LC-MS analysis with retention time of 30.4 mins (data not shown). Furthermore, masses corresponding to the hydroxylated form of quinovosyl 10-deoxymethynolide (m/ z = 481.5), quinovosyl narbonolide (m/z = 521.5) and its hydroxylated form (m/z = 537.6) were also detected from the culture broth of YJ019 with retention times of 15.0 mins, 34.9 mins and 24.3 mins, respectively (data not shown). The masses given correspond to the sodium adduct of each compound. The conversion yields of glycosylated compounds were 5% conversion for 10-deoxymethynolide and 6% for quinovosyl narbonolide. MS/ MS analysis of theses compounds produced the characteristic fragmentation pattern with a difference between Furthermore, the requirement of DesVIII for glycosylation from this study strengthens the hypothesis made in the previous report of the requirement of this additional protein for glycosylation [22] but its actual role remains to be elucidated.
Production of olivosyl derivatives
The strain YJ020, containing the glycosyltransferase (desVII) and TDP-D D-olivose synthesizing genes, did not produce the expected olivose glycosylated compounds. The requirement of the additional protein, Des-VIII, may also apply to transferring this non-native sugar and therefore strain YJ021 was constructed to incorporate the desVIII gene. Extract from culture supernatants of YJ021 was analysed by LC/ESI-MS/MS for the expected quinovosyl derivatives. The olivosyl 10-deoxymethynolide was detected at a retention time of 38.4 mins (Fig. 3(b) ) and gave the parent peak (Na + form) at m/z 449.6 and a fragmentation peak at m/z 319.4 corresponding to the aglycone (Fig. 4(a) ), 10-deoxymethynolide. This difference of 130 between the parent and daughter peak corresponds to the loss of the neutral olivose residue. The olivosyl narbonolide was detected at a retention time of 42.0 min (Fig. 3(c) ) and gave the parent peak (Na + form) at m/z 505. a fragmentation peak at m/z 375.4 corresponding to the aglycone, narbonolide (Fig. 4(b) ). The difference of 130 (compared to 505.4) again confirms the loss of the olivose residue. The structural identification of these compounds was based on MS/MS analysis and therefore the assignment of the glycosides as olivosyl compounds is only tentative. MS/MS analysis does not provide any information on the precise structure and stereochemistry of the sugar moiety and thus further analysis such as nuclear magnetic resonance (NMR) spectroscopy is required to confirm these compounds as olivosyl analogs.
The biosynthesis of olivosyl 10-deoxymethynolide and narbonolide shows that DesVII can accept TDP-D D-olivose as a sugar substrate, expanding the range of 6-deoxysugars which DesVII is able to accept and attach to the aglycone. The production of the expected compounds also demonstrates that DesVIII may be involved in the glycosylation process inconjunction with desVII, as a ''helper'' protein. OleV was able to modify the intermediate sugar (TDP-4-keto-6-dideoxysugar) and the heterologous pathway to TDP-D D-olivose was successfully accomplished. A similar approach of biosynthesizing TDP-D D-olivose utilizing oleS and oleE genes instead of desIII and desIV, respectively, has been reported previously [26] .
In addition, compounds corresponding to the hydroxylated forms of olivosyl 10-deoxymethynolide and narbonolide were also detected from the culture extract. Olivosyl analog of methymycin, with a hydroxyl group presumably at C-10 or C-12 position, was detected at 20.8 mins (Fig. 3(d) ) with a parent peak (Na + form) at m/z 465.6 and a fragmentation peak at 335.4 (Fig. 4(c) ). The olivosyl analog of pikromycin, with a hydroxyl group presumably at C-12, was detected at 29.4 mins (Fig. 3(e) ) with a parent peak (Na + form) at m/z 521.8 and a fragmentation peak at 391.5 ( Fig.  4(d) ). The MS/MS analyses of the hydroxylated compounds do not provide information on the position of the hydroxyl group of the aglycone. It is speculated that the cytochrome P450-hydroxylase (PikC), which normally catalyzes the hydroxylation of desosamine glycosylated 10-deoxymethynolide (YC-17) and narbonolide (narbomycin) [27] , may have hydroxylated the olivose glycosylated compounds.
One of the major challenges of combinatorial biosynthesis involving hybrid macrolides is the significantly low yield of hybrid compounds [14, 28] . The yield of the new macrolides produced from the mutant strain YJ021 required sensitive analytical methods such as LC-MS for detection. Moreover, the percentage conversion into the respective glycosylated compounds was generally low with 2% conversion for 10-deoxymethynolide and 3% for narbonolide, which complicates the quantitative analysis based on LC-MS.
In conclusion, the work presented here demonstrates the feasibility of combining genes from various deoxysugar pathways by genetic manipulation to engineer the biosynthesis of a non-native sugar. The successful generation of olivose glycosylated macrolides has further expanded the usefulness of this glycosyltransferases as a tool for combinatorial biosynthesis. It is hoped that this research based on a combinatorial biosynthetic approach will help the development of novel drugs against bacterial infections. Further work needs to be undertaken to produce these macrolides at large scale for bioactivity assays and in addition, in vitro studies for closer observation and characterization of DesVII and DesVIII should be helpful in elucidating their role in the glycosylation process.
